Doximity outlines 11% full-year revenue growth target as AI suite and Pathway acquisition accelerate platform expansion
Source: SeekingAlpha
2025-08-07 21:51:09 ET
More on Doximity
- Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
- Doximity: Slowing Sales And EBITDA Growth
- Doximity Crushes The Rule Of 40 - Try Rule Of 58
- Doximity Non-GAAP EPS of $0.36 beats by $0.05, revenue of $145.9M beats by $6.36M
- Biggest stock movers Friday: SPCE, AMAT, and more
Read the full article on Seeking Alpha
For further details see:
Doximity outlines 11% full-year revenue growth target as AI suite and Pathway acquisition accelerate platform expansion
Doximity Inc. Class A
NASDAQ: DOCS
DOCS Trading
-2.4% G/L:
$24.39 Last:
746,042 Volume:
$24.96 Open:
DOCS Latest News
February 23, 2026 01:35:00 am
Got $50,000? This Unbelievable SaaS Compounder Is Hiding in Plain Sight.
DOCS Stock Data
$5,029,624,926
180,645,361
N/A
184
N/A
Healthcare Providers & Services
Healthcare
US
San Francisco
